Table 1.

Demographics and clinical features of patients who were critically ill with COVID-19 with and without thrombocytopenia

Non-thrombocytopenic cohort, n=50Thrombocytopenic cohort, n=57p-value
Age, years, median (IQR)67.50 (53.50–73.00)61.00 (54.00–68.00)0.158
Women, n (%)14 (28.6)6 (10.5)0.034
BMI, kg/m 2, median (IQR)29.40 (26.25–33.62)27.90 (24.80–30.00)0.113
Diabetes, n (%)22 (44.0)19 (33.3)0.351
IHD, n (%)10 (20.0)8 (14.0)0.573
Malignancy, n (%)4 (8.0)4 (7.0)1.000
Haematological disorder, n (%)3 (6.0)4 (7.0)1.000
Hypertension, n (%)22 (44.0)27 (47.4)0.877
Dyslipidaemia, n (%)27 (54.0)21 (36.8)0.113
COPD/CLD, n (%)6 (12.0)4 (7.0)0.582
CRF, n (%)3 (6.0)9 (15.8)0.196
Thyroid disease, n (%)9 (18.0)3 (5.3)0.076
  • BMI = body mass index; COPD = chronic obstructive pulmonary disease; CLD = chronic lung disease; CRF = chronic renal failure; IHD = ischaemic heart disease; IQR = interquartile range.